Other HCV-modulated signaling pathways (i.e., NF-κB and STAT3) offer interesting opportunities to therapeutic intervention, as well as prevention, especially in the pathological context of HCC [189]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.